Bibliographic review. Juanes-Gusano, D.; Fernández-Roldán, B.; Coveñas, R. Hijazi, M. Targeting kinase signaling in glioblastoma: Structural optimization, blood-brain barrier dynamics and combinatorial translational strategies. Int. J. Mol. Sci. 2026, 27, 6590. doi: 10.3390/ijms27156590. Impact factor (JCR 2025) = 5.6

Scientific paper. Colomina-Basanta, C; Bazzi, M; Hijazi, M; Bessant, C; R.Cutillas, P (AC). (2023) Community detection in empirical kinase networks identifies new potential members of signalling pathways. PLoS Computational Biology. ISSN 1553-734X. DOI:10.1371/journal.pcbi.1010459. Impact factor (JCR 2023) = 3.8

Scientific paper. Prieto-Fernandez, L*; Villaronga, MA*; Hermida-Prado, F; ...Alvarez-Teijeiro, S. (AC) (2023) Driving role of head and neck cancer cell secretome on the invasion of stromal fibroblasts: Mechanistic insights by phosphoproteomics. Biomedicine & Pharmacotherapy. ISSN 0753-3322. DOI:10.1016/j.biopha.2022.114176 (* these authors contributed equally). Impact factor (JCR 2023) = 6.9

Book chapter. Casado, P; Hijazi, M; Gerdes, H; R.Cutillas, P (AC). (2022) Implementation of clinical phosphoproteomics and proteomics for personalized medicine Methods in Molecular Biology. ISBN 978-1-0716-1935-3. https://doi.org/10.1007/978-1-0716-1936-0_8

Scientific paper. Hijazi, M. (AC), Casado, P., Akhtar, N., Alvarez-Teijeiro, S., Rajeeve, V. and Cutillas, P. (AC) (2022) eEF2K activity determines synergy to cotreatment of cancer cells with PI3K and MEK inhibitors. Mol Cell Proteomics 21(6):100240. DOI: 10.1016/j.mcpro.2022.100240. Impact factor (JCR 2022) = 7.0

Scientific paper. Pedicona, F*., Casado, P*., Hijazi, M*., Gribben, J., Rouault-Pierre, K., Cutillas, P. (AC) (2022) Targeting the lysine demethylase LSD1 rewires kinase networks and primes leukemia cells for kinase inhibitor sensitivity. Science Signaling 19; 15(730):eabl7989. DOI: 10.1126/scisignal.abl7989 (* these authors contributed equally). Impact factor (JCR 2022) = 7.3

Scientific paper. Gerdes, H*., Casado, P*., Dokal, A*., Hijazi, M*.,…Cutillas, P. (AC). (4/12) (2021) Drug ranking using machine learning (DRUML) systematically predicts the efficacy of anti-cancer drugs. Nature Communications 12, 1850. DOI: 10.1038/s41467-021-22170-8 (* these authors contributed equally). Impact factor (JCR 2021) = 17.694

Scientific paper. Hijazi, M., Smith, R., Rajeeve, V., Bessant, C., Cutillas, P. (AC). (2020) Reconstructing kinase network topologies from phosphoproteomics data reveals cancer associated rewiring. Nature Biotechnology 38(4):493-502. DOI: 10.1038/s41587-019-0391-9. Impact factor (JCR 2020) = 54.908

Scientific paper. Wong, P*. (AC), Muñoz-Félix, J.M*. (AC), Hijazi, M.,,…Hodivala-Dilke, K. (AC). (3/32) (2020) Cancer burden is controlled by mural cell-β3-integrin regulated crosstalk with tumor cells. Cell 181(6):1346-1363. DOI: 10.1016/j.cell.2020.02.003 (* these authors contributed equally). Impact factor (JCR 2020) = 41.584

Scientific paper. Invergo, B., Petursson, B., Akhtar, N.,…Beltrao, P. (AC). (6/9) (2020) Prediction of signed protein kinase regulatory circuits. Cell Systems 10(5):384-396. DOI: 10.1016/j.cels.2020.04.005. Impact factor (JCR 2020) = 10.304

Scientific paper. Martin-Guerrero, S. (AC), Casado, P., Hijazi, M.,…Martin-Oliva, D. (3/10) (2020) PARP-1 activation after oxidative insult promotes energy stress-dependent phosphorylation of YAP1 and reduces cell viability. Biochemical Journal 477(23):4491-4513. DOI: 10.1042/BCJ20200525. Impact factor (JCR 2020) = 3.857

Bibliographic review. Casado, P., Hijazi, M., Britton, D., Cutillas, P. (AC). (2017) Impact of phosphoproteomics in the translation of kinase targeted therapies. Proteomics 17(6). DOI: 10.1002/pmic.201600235. Impact factor (JCR 2017) = 3.532

Scientific paper. Hijazi, M., Medina, J.M., Velasco, A. (AC). (2017) Restrained phosphatidylcholine synthesis in a cellular model of Down’s syndrome is associated with the overexpression of Dyrk1A. Molecular Neurobiology 54(2): 1092-1100. DOI: 10.1007/s12035-016-9728-2. Impact factor (JCR 2017) = 5.076

Scientific paper. Hijazi, M., Fillat, C., Medina, J.M., Velasco, A. (AC). (2013) Overexpression of Dyrk1A inhibits choline acetyltransferase induction by oleic acid in cellular models of Down syndrome. Experimental Neurology 239, 229-234. Highlighted article. DOI: 10.1016/j.expneurol.2012.10.016. Impact factor (JCR 2013) = 4.617